- Home
- COHN vs APM Comparison
COHN vs APM Comparison
Compare COHN & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COHN
- APM
- Stock Information
- Founded
- COHN 1999
- APM 2010
- Country
- COHN United States
- APM United Kingdom
- Employees
- COHN N/A
- APM N/A
- Industry
- COHN Investment Bankers/Brokers/Service
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- COHN Finance
- APM Health Care
- Exchange
- COHN Nasdaq
- APM Nasdaq
- Market Cap
- COHN 21.6M
- APM 18.9M
- IPO Year
- COHN N/A
- APM 2018
- Fundamental
- Price
- COHN $11.27
- APM $1.82
- Analyst Decision
- COHN
- APM
- Analyst Count
- COHN 0
- APM 0
- Target Price
- COHN N/A
- APM N/A
- AVG Volume (30 Days)
- COHN 4.5K
- APM 329.0K
- Earning Date
- COHN 11-03-2025
- APM 04-30-2025
- Dividend Yield
- COHN 9.09%
- APM N/A
- EPS Growth
- COHN 37.63
- APM N/A
- EPS
- COHN 1.14
- APM N/A
- Revenue
- COHN $133,173,000.00
- APM N/A
- Revenue This Year
- COHN N/A
- APM N/A
- Revenue Next Year
- COHN N/A
- APM N/A
- P/E Ratio
- COHN $9.66
- APM N/A
- Revenue Growth
- COHN 78.63
- APM N/A
- 52 Week Low
- COHN $6.10
- APM $0.46
- 52 Week High
- COHN $13.25
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- COHN 45.71
- APM 49.94
- Support Level
- COHN $10.90
- APM $1.74
- Resistance Level
- COHN $11.49
- APM $1.80
- Average True Range (ATR)
- COHN 0.34
- APM 0.12
- MACD
- COHN -0.05
- APM -0.02
- Stochastic Oscillator
- COHN 38.61
- APM 35.48
About COHN Cohen & Company Inc.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.